SOLVD prevention trial
Jump to navigation
Jump to search
Introduction
29% reduction in death or development in overt heart failure over a 3 year period in patients with asymptomatic left ventricular dysfunction.
More general terms
Additional terms
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998